71 filings
Page 3 of 4
10-K
hpo2jxpwud ad4
10 Mar 22
Annual report
6:38am
8-K
o9alp8
10 Mar 22
Immuneering Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
6:30am
8-K
ry07a1lq5wx1 tud9
18 Jan 22
Industry Executive Brings More than 20 Years of Clinical Drug Development Expertise
6:56am
8-K
cvpfwd9
22 Dec 21
Entry into a Material Definitive Agreement
6:04am
8-K
kfskd66frplpqn 007d
9 Nov 21
Immuneering Reports Third Quarter 2021 Financial Results and Recent Business Highlights
6:30am
10-Q
6rmknm oclwyurlaj7ib
9 Sep 21
Quarterly report
6:41am
8-K
g8bm vuuxkuu0
9 Sep 21
Immuneering Reports Second Quarter 2021 Financial Results and Provides Business Updates
6:30am
S-8
tgg3xlmb4mfow
3 Aug 21
Registration of securities for employees
4:47pm
424B4
fap0uch
30 Jul 21
Prospectus supplement with pricing info
4:13pm
EFFECT
tgnn 6g34lwo9ht
30 Jul 21
Notice of effectiveness
12:16am
S-1MEF
hcj er774rmd
29 Jul 21
Registration of additional securities for an S-1
8:34pm
CORRESP
13qpv1cjfcr
28 Jul 21
Correspondence with SEC
12:00am
CERT
ugbjnl nn7dk
27 Jul 21
Certification of approval for exchange listing
4:58pm
CORRESP
lajiyc
27 Jul 21
Correspondence with SEC
12:00am
UPLOAD
unuz7 3ys
27 Jul 21
Letter from SEC
12:00am
CORRESP
kbp4xuu584x
27 Jul 21
Correspondence with SEC
12:00am
8-A12B
h4d8by4mgj
27 Jul 21
Registration of securities on exchange
12:00am
S-1/A
ish6fpvlq5 kb
26 Jul 21
IPO registration (amended)
6:03am